Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : Nasdaq Stockholm

Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies

Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies
03/31/2026 | Companies
Swedish Orphan Biovitrum AB has published its 2025 Annual and Sustainability Report, highlighting the company’s achievements in advancing innovative therapies for people living with rare diseases. Sobi continues to prioritize sustainable growth through collaboration and scientific expertise,...
annual report 2025, biopharma, breakthrough medicines, corporate sustainability, CSRD, ESRS, EU Taxonomy, global biopharma, healthcare access, innovative therapies, Nasdaq Stockholm, patient care, pharmaceutical revenue, pipeline development, rare disease treatments, rare diseases, scientific expertise, Sobi, sustainability report 2025, Swedish Orphan Biovitrum, TCFD

Truecaller Share Buyback Update: Weekly Repurchase Summary and Holdings

Truecaller Share Buyback Update: Weekly Repurchase Summary and Holdings
02/23/2026 | Companies
The share repurchases are part of the buyback programme announced by Truecaller on 30 May 2025. This programme is scheduled to run from 30 May 2025 until the company’s Annual General Meeting (AGM) in May 2026 and is conducted in compliance with the “Emittentregelverket” framework. At the 2025...
AGM 2026, annual general meeting, B-shares, board authorization, C-shares, Carnegie, corporate finance, cumulative buybacks, Emittentregelverket, financial disclosure, investor relations, Nasdaq Stockholm, press release, share buyback, share repurchase programme, shareholder capital, stock transactions, transaction value, treasury shares, Truecaller, weighted average share price


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com